Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Bitcoin USD

    70,943.36
    +2,231.99 (+3.25%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.19
    +5.70 (+0.11%)
     
  • Dow

    39,801.76
    +41.68 (+0.10%)
     
  • Nasdaq

    16,381.27
    -18.25 (-0.11%)
     
  • Gold

    2,243.00
    +30.30 (+1.37%)
     
  • Crude Oil

    82.98
    +1.63 (+2.00%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Synergy Pharmaceuticals (SGYP) Jumps: Stock Up 10.9%

Synergy Pharmaceuticals, Inc. (SGYP) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 10, as the stock is now trading above the volatile price range of $4.16 to $4.62.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Synergy Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked medical stocks include Enanta Pharmaceuticals, Inc. (ENTA), Questcor Pharmaceuticals, Inc. (QCOR) and ImmunoGen, Inc. (IMGN). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SYNERGY PHARMACEUTICALS DE (SGYP): Free Stock Analysis Report

QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report

IMMUNOGEN INC (IMGN): Free Stock Analysis Report

ENANTA PHARMACEUTICALS INC (ENTA): Free Stock Analysis Report


Zacks Investment Research